Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells

References

• Abbott NJ, Rönnbäck L, Hansson E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41–53.
   PubMed Web of Science ®Google Scholar
• Bachurin SO. (2003). Medicinal chemistry approaches for the treatment and prevention of Alzheimer’s disease. Med Res Rev 23:48–88.
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. (2004). Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56:1649–1659.
   PubMed Web of Science ®Google Scholar
• Camps P, Muñoz-Torrero D. (2002). Cholinergic drugs in pharmacotherapy of Alzheimer’s disease. Mini Rev Med Chem 2:11–25.
   PubMed Web of Science ®Google Scholar
• Carlsen A, Lecommandoux S. (2009). Self-assembling of polypeptide-based block copolymer amphiphiles. Curr Opin Colloid Interface Sci 14:329–339.
   Web of Science ®Google Scholar
• Cavallaro G, Licciardi M, Scirè S, Di Stefano M, Giammona G. (2010). New pegylated polyaspartamide-based polyplexes as gene delivery vectors. Nanomedicine (Lond) 5:243–258.
   PubMed Web of Science ®Google Scholar
• Cavallaro G, Scirè S, Licciardi M, Ogris M, Wagner E, Giammona G. (2008). Polyhydroxyethylaspartamide-spermine copolymers: efficient vectors for gene delivery. J Control Release 131:54–63.
   PubMed Web of Science ®Google Scholar
• Chen J, Jiang M, Zhang Y, Zhou H. (1999). Fluorescence studies on hydrophobic association of fluorocarbon-modified poly(acrylic acid) solution. Macromolecules 32:4862–4866.
   Google Scholar
• Christopher B. (2009). Squalene emulsions for parenteral vaccine and drug delivery. Molecules 14:3286–3312.
   PubMed Web of Science ®Google Scholar
• Civiale C, Licciardi M, Cavallaro G, Giammona G, Mazzone MG. (2009). Polyhydroxyethylaspartamide-based micelles for ocular drug delivery. Int J Pharm 378:177–186.
   PubMed Web of Science ®Google Scholar
• Craparo EF, Ognibene MC, Casaletto MP, Pitarresi G, Teresi G, Giammona G. (2008). Biocompatible polymeric micelles with polysorbate 80 for use in brain targeting. Nanotechnology 19:485603.
   PubMed Web of Science ®Google Scholar
• Craparo EF, Teresi G, Bondi’ ML, Licciardi M, Cavallaro G. (2011). Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids. Int J Pharm 406:135–144.
   PubMed Web of Science ®Google Scholar
• Giammona G, Carlisi B, Palazzo S. (1987). Reaction of α,β-poly(N-2-hydroxyethyl)- d,l aspartamide with derivatives of carboxylic acids. J Polym Sci Polym Chem 25:2813–2818.
   Web of Science ®Google Scholar
• Kelly GS. (1999). Squalene and its potential clinical uses. Altern Med Rev 4:29–36.
   PubMedGoogle Scholar
• Know GS, Okano T. (1996). Polymeric micelles as new drug carrier. Adv Drug Deliv Rev 21:107–116.
   Web of Science ®Google Scholar
• Kreuter J. (2001). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65–81.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2002). Transport of drugs across the blood-brain barrier by nanoparticles. Curr Med Chem Central Nervous Syst Agent 2:241–249.
   Google Scholar
• Licciardi M, Campisi M, Cavallaro G, Cervello M, Azzolina A, Giammona G. (2006). Synthesis and characterization of polyaminoacidic polycations for gene delivery. Biomaterials 27:2066–2075.
   PubMed Web of Science ®Google Scholar
• Licciardi M, Cavallaro G, Di Stefano M, Fiorica C, Giammona G. (2011). Polyaspartamide-graft-polymethacrylate nanoparticles for doxorubicin delivery. Macromol Biosci 11:445–454.
   PubMed Web of Science ®Google Scholar
• Liu CX. (2011). Research and application of targeting nano-drugs. Nano Biomed Eng 3:73–83.
   Google Scholar
• Lockman PR, Koziara JM, Mumper RJ, Allen DD. (2004). Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 12:635–641.
   PubMed Web of Science ®Google Scholar
• Mendichi R, Giammona G, Cavallaro G, Giacometti Schieroni A. (2000). Molecular characterization of alpha,beta-poly(N-hydroxyethyl)- d, l -aspartamide by light scattering and viscometry studies. Polymer 41:649–657.
   Google Scholar
• Ognibene MC, Rocco F, Craparo EF, Picone P, Ceruti M, Giammona G. (2011). Biocompatible micelles based on squalene portions linked to PEGylated polyaaspartamide as potential colloidal drug carriers. Current Nanosci 7:747–756.
   Web of Science ®Google Scholar
• Pardridge WM. (1999). Blood-brain barrier biology and methodology. J Neurovirol 5:556–569.
   PubMed Web of Science ®Google Scholar
• Park K. (2009). Transport across the blood-brain barrier using albumin nanoparticles. J Control Release 137:1.
   Google Scholar
• Pitarresi G, Palumbo FS, Albanese A, Licciardi M, Calascibetta F, Giammona G. (2008). In situ gel forming graft copolymers of a polyaspartamide and polylactic acid: preparation and characterization. Eur Polym J 44:3764–3775.
   Web of Science ®Google Scholar
• Rao BM, Srinivasu MK, Kumar KP, Bhradwaj N, Ravi R, Mohakhud PK, Reddy GO, Kumar PR. (2005). A stability indicating LC method for rivastigmine hydrogen tartrate. J Pharm Biomed Anal 37:57–63.
   PubMed Web of Science ®Google Scholar
• Schroeder U, Sommerfeld P, Sabel BA. (1998). Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier. Peptides 19:777–780.
   PubMed Web of Science ®Google Scholar
• Smith TJ. (2000). Squalene: potential chemopreventive agent. Expert Opin Investig Drugs 9:1841–1848.
   PubMed Web of Science ®Google Scholar
• Voets JK, Keizer A, Cohen Stuart MA. (2006). Core and corona structure of mixed polymeric micelles. Macromolecules 39:5952–5955.
   Web of Science ®Google Scholar
• Williams BR, Nazarians A, Gill MA. (2003). A review of rivastigmine: a reversible cholinesterase inhibitor. Clin Ther 25:1634–1653.
   PubMed Web of Science ®Google Scholar
• Yang H. (2010). Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharm Res 27:1759–1771.
   PubMed Web of Science ®Google Scholar
• Yang QQ, Zhou Q, Somasundaran P. (2009). 1H NMR study of micelles formed by mixture of nonionic n-dodecyl-β- d -maltoside and cationic gemini surfactants. J Mo liquids 146:105–111.
   Web of Science ®Google Scholar